drugset / Trial / NCT02656212
Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2)
Phase 1
Completed
15 enrolled
Veterans Medical Research Foundation
National Center for Complementary and Integrative Health (NCCIH) · collabNational Institutes of Health (NIH) · collabSan Diego Veterans Healthcare System · collabUniversity of California, San Diego · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This will be a double-blind, randomized, placebo-controlled, single dose study of (+)- epicatechin with one 30mg dose/day for a total of 7 days
Timeline
- Start
- 2015-09
- Primary completion
- 2016-04
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | (-)-Epicatechin | Unknown | 30 mg | Oral |